- Home
- Central Nervous System Insomnia or Sleep Disorders
Central Nervous System Insomnia or Sleep Disorders
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
NRT Smoking Cessation Aids Market Analysis in Ireland
- $ 898
- Industry report
- by Euromonitor International
- June 2013
- 22 pages
This was a further bid to raise and maintain awareness of the associated risks of smoking and hence to reduce the numbers of smokers and those taking up the habit in the first place. These regulations were being drafted in 2011 with implementation expected before the end of the year, or in early 2012 ...
Industries: Tobacco, Pathology | Countries: Ireland
Triple Analysis: Leukemia, Melanoma and Peptides
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 3341 pages
This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development ...
Industries: Pathology
Triple Analysis: Melanoma, Prostate Cancer and Apoptosis
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 4291 pages
This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare ...
Industries: Pathology
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 5876 pages
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology ...
Industries: Pathology
Triple Analysis: Lung Cancer, Lymphoma and Melanoma
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 3458 pages
This triple analysis focuses on cancer drug development strategies in Lung Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This ...
Industries: Pathology
Triple Analysis: Lung Cancer, Melanoma and Peptides
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 3517 pages
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development ...
Industries: Pathology
Triple Analysis: Melanoma, Prostate Cancer and Angiogenesis
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 4378 pages
This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare ...
Industries: Pathology
Triple Analysis: Breast Cancer, Melanoma and Antibodies
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 5297 pages
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug ...
Industries: Pathology
Triple Analysis: Lung Cancer, Melanoma and Angiogenesis
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 4208 pages
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare ...
Industries: Pathology
Triple Analysis: Lymphoma, Melanoma and Peptides
- $ 5 175
- Industry report
- by Bioseeker
- June 2013
- 3148 pages
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development ...
Industries: Pathology
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 213 49 04
ref:plp2009
Reportlinker.com © Copyright 2013. All rights reserved.
